Antioxidant properties of lipoic acid and its therapeutic effects in prevention of diabetes complications and cataracts.
Packer
L
L
Department of Molecular and Cell Biology, University of California at Berkeley 94720.
D000818:Animals; D000963:Antimetabolites / Q000633:toxicity; D000975:Antioxidants / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D019328:Buthionine Sulfoximine; D002386:Cataract / Q000139:chemically induced / Q000517:prevention & control*; D003921:Diabetes Mellitus, Experimental / Q000503:physiopathology*; D003930:Diabetic Retinopathy / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007908:Lens, Crystalline / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D008717:Methionine Sulfoximine / Q000031:analogs & derivatives / Q000633:toxicity; D051381:Rats; D017208:Rats, Wistar; D008063:Thioctic Acid / Q000494:pharmacology* / Q000627:therapeutic use
D000963:Antimetabolites; D000975:Antioxidants; D008717:Methionine Sulfoximine; D019328:Buthionine Sulfoximine; D008063:Thioctic Acid